Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Location: Boston MA, New Haven CT, Rochester MN, Miami FL,
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18+
Code: NCT07303816
Recruiting
Pathways to Perinatal Mental Health Equity
for
Perinatal Anxiety, Perinatal Depression,
Location: Shrewsbury MA
Sponsor: University of Massachusetts, Worcester
Sex: All
Age: 18 - 70
Code: NCT06790641
Recruiting
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
for
Aneurysm, Aneurysm, Intracranial
Location: Burlington MA, Stony Brook NY, The Bronx NY,
Sponsor: Stryker Neurovascular
Sex: All
Age: 18 - 70+
Code: NCT06872684
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of YL242 in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Boston MA, New Haven CT, Grand Rapids MI, Nashville TN,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07197827
Phase 1, Phase 2, Recruiting
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Boston MA, New Haven CT, Fairfax VA, Cleveland OH,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07155174
Phase 2, Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
for
Gastrointestinal Neoplasms
Location: Boston MA, New Haven CT, New Hyde Park NY, New York NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07218926
Phase 3, Recruiting
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
for
Metastatic Malignant Solid Neoplasm,
Location: Boston MA, Columbus OH, Lexington KY, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05372614
Phase 1, Recruiting
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
Location: Boston MA, Durham NC, Atlanta GA, Houston TX, Orange CA
Sponsor: Philogen S.p.A.
Sex: All
Age: 18+
Code: NCT07228442
Phase 2, Recruiting
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
for
Carcinoma, Renal Cell
Location: Boston MA, New York NY, Hackensack NJ, Morristown NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07489495
Phase 3, Recruiting
Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study
for
Stage II Lung Cancer, Lung Cancer, Non-small Cell Lung Cancer,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT07412041
Recruiting
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Boston MA, Bethlehem PA, Mullica Hill NJ, Fairfax VA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07365241
Phase 3, Recruiting
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Location: Boston MA, Fort Wayne IN, St Louis MO, Tampa FL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06697184
Phase 1, Phase 2, Recruiting
Supporting Health Including Endocrine Treatment for Long Duration
for
Breast Cancer, Breast Cancer - Female, Breast Carcinoma,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: Female
Age: 18 - 49
Code: NCT07482384
Recruiting
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
for
Colorectal Cancer, Pancreatic Cancer,
Location: Boston MA, Fairfax VA, San Antonio TX,
Sponsor: PAQ Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07300150
Phase 1, Recruiting
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Boston MA, Montreal, Farmington Hills MI, Columbus OH,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07541170
Phase 3, Recruiting
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
for
Renal Cell Carcinoma
Location: Boston MA, New York NY, Philadelphia PA, Nashville TN,